Mycophenolic acid-related anemia and leucopenia in renal transplant recipients are related to genetic polymorphisms in CYP2C8

Transplantation

Volumn 93, Issue 10, 2012, Pages

  Bouamar, Rachida ^a   Elens, Laure ^a   Shuker, Nauras ^a   Van Schaik, Ron H N ^a   Weimar, Willem ^a   Hesselink, Dennis A ^a   Van Gelder, Teun ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; CYCLOSPORIN; CYTOSINE; GENOMIC DNA; GUANINE; INTERLEUKIN 12P35; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMINE;

ANEMIA; CONTROLLED STUDY; CYP2C8 GENE; DNA ISOLATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GRAFT RECIPIENT; HETEROZYGOTE; HUMAN; HUS1 GENE; IL12A GENE; KIDNEY TRANSPLANTATION; LETTER; LEUKOPENIA; MAJOR CLINICAL STUDY; PHARMACOGENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ANEMIA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; MYCOPHENOLIC ACID; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84861043247     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182488bb4     Document Type: Letter

References (8)

1. Jacobson PA, Schladt D, Oetting WS, et al. Genetic determinants of mycophenolaterelated anemia and leukopenia after transplantation. Transplantation 2011; 91: 309.
2. van Gelder T, Silva HT, de Fijter JW, et al. Comparing mycophenolate mofetil regimens for de novo renal transplant recipients: The fixed-dose concentration-controlled trial. Transplantation 2008; 86: 1043.
3. van Schaik RH, van Agteren M, de Fijter JW, et al. UGT1A9-275T9A/-2152C9T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients. Clin Pharmacol Ther 2009; 86: 319.
4. Senn SJ. Power is indeed irrelevant in interpreting completed studies. BMJ 2002; 325: 1304.
5. Schulz KF, Grimes DA. Sample size calculations in randomised trials: Mandatory and mystical. Lancet 2005; 365: 1348.
6. Vandenbroucke JP, von Elm E, Altman DG, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration. Epidemiology 2007; 18: 805.
7. Danesi R, Del Tacca M. Hematologic toxicity of immunosuppressive treatment. Transplant Proc 2004; 36: 703.
8. van Gelder T, Hilbrands LB, Vanrenterghem Y, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation. Transplantation 1999; 68: 261.